Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

PDS Biotechnology Corp

NASDAQ: PDSB · Life Sciences · 8 alerts · CIK 1472091

Share price
$0.9241Close, Nov 16
Market cap
$97M
Shares outstanding
105.01MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All PDS Biotechnology Corp filings on SEC EDGAR ↗

6:02 AM ET 8-K
Investor Presentation

PDS Biotechnology Investor Presentation

PDS Biotechnology updated its corporate presentation deck for October 2026, providing an overview of its oncology drug development programs. The presentation includes updates on its Versamune-based product candidates, including PDS0101 and PDS0301, and discusses the company's research and development strategy.

4:06 PM ET 8-K
Investor Presentation

PDS Biotechnology Investor Presentation

PDS Biotechnology Corporation filed an updated corporate presentation deck as an exhibit to its 8-K. The presentation provides an overview of the company's oncology drug development programs, including PDS0101 and PDS0301, as of September 2026. This filing serves as a strategic update for investors regarding the company's clinical trial pipeline and research collaborations.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.